Therapeutic Asset Ratings
8,400 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ipilimumab
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)
P1/2
CCC
(55)
Ipilimumab
Ovarian Serous Adenocarcinoma
TCR2 Therapeutics
P1/2
CCC
(55)
Irinotecan
Gastric Carcinoma
City of Hope Medical Center
P1/2
CCC
(55)
Irinotecan
Mesothelioma
Genmab
P1/2
CCC
(55)
Irinotecan
Metastatic Gastric Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(55)
Montanide Isa 51
Colorectal Cancer
Roswell Park Cancer Institute
P1/2
CCC
(55)
Nivolumab
Hormone Receptor-Positive Breast Cancer
Fred Hutchinson Cancer Center
P1/2
CCC
(55)
Nivolumab
Carcinoma
Asan Medical Center
P1/2
CCC
(55)
Palbociclib
Acute Myeloid Leukemia
Thomas Jefferson University
P1/2
CCC
(55)
pe0116
Metastatic Neoplasm
Shanghai HyaMab Biotech Co.,Ltd.
P1/2
CCC
(55)
Pembrolizumab
Uterine Cancer
Kineta Inc.
P1/2
CCC
(55)
PREDNISONE TABLETS
Cutaneous Melanoma
National Cancer Institute (NCI)
P1/2
CCC
(55)
Rapamycin
Cutaneous Melanoma
National Cancer Institute (NCI)
P1/2
CCC
(55)
Regorafenib
Refractory Malignant Neoplasm
China Medical University, China
P1/2
CCC
(55)
Ribociclib
Non-Small Cell Lung Carcinoma
Novartis Pharmaceuticals
P1/2
CCC
(55)
Selinexor
Refractory Malignant Neoplasm
National University Hospital, Singapore
P1/2
CCC
(55)
Surufatinib
Neoplasm
Hutchmed
P1/2
CCC
(55)
Talzenna
Primary Peritoneal Carcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(55)
Tinengotinib
Cancer
TransThera Sciences (Nanjing), Inc.
P1/2
CCC
(55)
Tinengotinib
Gallbladder Cancer
TransThera Sciences (Nanjing), Inc.
P1/2
CCC
(55)
Tocilizumab
Primary Mediastinal Large B-Cell Lymphoma
Jonsson Comprehensive Cancer Center
P1/2
CCC
(55)
TTI 101
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated
P1/2
CCC
(55)
Upifitamab Rilsodotin
Ovarian Cancer
Mersana Therapeutics
P1/2
CCC
(55)
(+)-VINCRISTINE
B-Cell Neoplasm
National Cancer Institute (NCI)
P1/2
CCC
(55)
(+)-VINCRISTINE
Refractory Solid Tumors
Theodore Laetsch
P1/2
CCC
(55)
Showing 251 to 275 of 8,400 assets
Previous
Page 11 of 336
Next